BRCA2 Deficiency in Prostate Cancer

preview Add to My Pictures


Title: BRCA2 Deficiency in Prostate Cancer
Description: NHGRI researchers and their collaborators have identified a specific genomic signature of some aggressive prostate tumors, which may help pinpoint specific treatment options. Their work focuses on BRCA2 mutations, which are associated with breast and ovarian cancer, but also increase men's risk for prostate cancer. Both men and women can inherit a faulty BRCA2 gene from either their mother or father. When working properly, the BRCA2 gene helps stop cells from becoming cancerous by producing proteins that fix damage to DNA.
Topics/Categories: Cancer Types -- Prostate Cancer
Type: Color, Illustration
Source: National Institutes of Health
Creator: Ernesto del Aguila III, National Human Genome Research Institute, NIH
Date Created: April 14, 2016
Date Added: January 9, 2018
Reuse Restrictions: None - This image is in the public domain and can be freely reused. Please credit the source and, where possible, the creator listed above.